Published in J Lipid Res on July 01, 1970
The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. J Clin Invest (1972) 3.43
Enzyme deficiency in cholesteryl ester storage idisease. J Clin Invest (1972) 1.32
Renal lipid metabolism and lipotoxicity. Curr Opin Nephrol Hypertens (2010) 1.05
Effects of lipid regulation using raw and processed radix polygoni multiflori in rats fed a high-fat diet. Evid Based Complement Alternat Med (2012) 0.91
The spleen in type I hyperlipoproteinemia. Histochemical, biochemical, microfluorometric and electron microscopic observations. Am J Pathol (1971) 0.87
Hepatic entrapment of esterified cholesterol drives continual expansion of whole body sterol pool in lysosomal acid lipase-deficient mice. Am J Physiol Gastrointest Liver Physiol (2014) 0.84
Differences in liver ganglioside patterns in various inbred strains of mice. Biochem J (1983) 0.81
Lipid composition of lymphocyte plasma membrane from pig mesenteric lymph node. Biochem J (1976) 0.81
The cell-envelope glycolipids of baker's yeast. Biochem J (1974) 0.81
Transitions of histopathologic criteria for diagnosis of nonalcoholic fatty liver disease during the last three decades. World J Hepatol (2014) 0.79
Plasma phospholipids indicate impaired fatty acid homeostasis in preterm infants. Eur J Nutr (2014) 0.77
Liver fat accumulation as a barometer of insulin responsiveness again points to adipose tissue as the culprit. Hepatology (2017) 0.75
Prevention Mechanism of 2,3,5,4'-Tetrahydroxy-stilbene-2-O-β-D-glucoside on Lipid Accumulation in Steatosis Hepatic L-02 Cell. Pharmacogn Mag (2017) 0.75
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 6.51
Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ (1970) 5.58
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 4.09
Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation (1974) 3.29
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 3.09
Studies of the proteins in human plasma very low density lipoproteins. J Biol Chem (1969) 2.98
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 2.86
Use of robust variance components models to analyse triglyceride data in families. Ann Hum Genet (1985) 2.52
The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick diseae. Proc Natl Acad Sci U S A (1966) 2.32
A specific apoprotein activator for lipoprotein lipase. Biochem Biophys Res Commun (1970) 2.24
Rationale of the diet-heart statement of the American Heart Association. Report of Nutrition Committee. Circulation (1982) 2.21
Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc Natl Acad Sci U S A (1980) 2.13
Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis (1984) 1.73
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA (1999) 1.70
Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia. J Clin Invest (1974) 1.66
Comparison of the effects of lean red meat vs lean white meat on serum lipid levels among free-living persons with hypercholesterolemia: a long-term, randomized clinical trial. Arch Intern Med (1999) 1.57
Effect of gemfibrozil in men with primary isolated low high-density lipoprotein cholesterol: a randomized, double-blind, placebo-controlled, crossover study. Am J Med (1993) 1.56
Mapping a gene involved in regulating dietary cholesterol absorption. The sitosterolemia locus is found at chromosome 2p21. J Clin Invest (1998) 1.55
A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques. J Clin Invest (1969) 1.54
Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann Intern Med (1982) 1.53
Cardiovascular pathology in hyperlipoproteinemia. Anatomic observations in 42 necropsy patients with normal or abnormal serum lipoprotein patterns. Am J Cardiol (1973) 1.52
The effect of filtered-coffee consumption on plasma lipid levels. Results of a randomized clinical trial. JAMA (1992) 1.50
Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood. J Clin Invest (1974) 1.50
The nature of pre beta (very low density) lipoproteins. J Clin Invest (1966) 1.48
Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol. Circulation (1992) 1.45
Comparison of the triglyceride lipase of liver, adipose tissue, and postheparin plasma. J Lipid Res (1972) 1.44
Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. Proc Natl Acad Sci U S A (1999) 1.42
On the protein defect in abetalipoproteinemia. N Engl J Med (1971) 1.40
Late clinical presentation of partial carbamyl phosphate synthetase I deficiency. Am J Dis Child (1993) 1.40
Type IV hyperlipoproteinaemia. Clin Endocrinol Metab (1973) 1.38
Plasma high-density lipoproteins and ischemic heart disease: studies in a large kindred with familial hypercholesterolemia. Ann Intern Med (1978) 1.38
Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins. Circ Res (1973) 1.33
Neonatal diagnosis of familial type-II hyperlipoproteinaemia. Lancet (1973) 1.32
Enzyme deficiency in cholesteryl ester storage idisease. J Clin Invest (1972) 1.32
Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC). Pediatrics (2001) 1.30
Further separation of the apoproteins of the human plasma very low density lipoproteins. Biochim Biophys Acta (1970) 1.28
Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease. Am J Cardiol (1990) 1.27
Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. Proc Natl Acad Sci U S A (2000) 1.26
The pathology of Tangier disease. A light and electron microscopic study. Am J Pathol (1975) 1.26
The biochemical, clinical, and genetic features of type III hyperlipoproteinemia. Ann Intern Med (1975) 1.24
Diagnosis and management of hyperlipoproteinemia. Am J Cardiol (1968) 1.23
Immunoreactive insulin, glucose tolerance, and carbohydrate inducibility in types II, 3, IV, and V hyperlipoproteinemia. Diabetes (1969) 1.22
Mutants, hyperlipoproteinaemia, and coronary artery disease. Br Med J (1971) 1.21
Tangier disease (familial high density lipoprotein deficiency). Clinical and genetic features in two adults. Am J Med (1965) 1.17
It's time to be practical. Circulation (1975) 1.16
The lipoproteins and lipid transport in abetalipoproteinemia. J Clin Invest (1966) 1.15
Selective measurement of two different triglyceride lipase activities in rat postheparin plasma. J Lipid Res (1973) 1.15
The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease. Am J Epidemiol (1979) 1.15
Characterization, subcellular localization, and partial purification of a heparin-released triglyceride lipase from rat liver. J Biol Chem (1973) 1.14
Further characterization of apolipoproteins from the human plasma very low density lipoproteins. J Biol Chem (1970) 1.14
The differentiation of exogenous and endogenous hyperlipemia by paper electrophoresis. J Clin Invest (1965) 1.14
Isolation and characterization of an abnormal high density lipoprotein in Tangier Diesase. J Clin Invest (1977) 1.13
Fat and cholesterol intakes of white adults in Columbia, Maryland. Upper-middle socioeconomic level subjects. J Am Diet Assoc (1982) 1.13
Evidence for the identity of the major apoprotein in low density and very low density lipoproteins in normal subjects and patients with familial hyperlipoproteinemia. J Clin Invest (1972) 1.13
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 1.12
Thf complete amino acid sequence of C-I (apoLp-Ser), an apolipoprotein from human very low density lipoproteins. J Biol Chem (1975) 1.12
Further characterization of the apolipoproteins of rat plasma lipoproteins. Biochemistry (1970) 1.12
The apolipoproteins. Adv Exp Med Biol (1972) 1.12
Studies on the protein defect in Tangier disease. Isolation and characterization of an abnormal high density lipoprotein. J Clin Invest (1972) 1.12
Deficiency of sphingomyelin-cleaving enzyme activity in tissue cultures derived from patients with Niemann-Pick disease. Biochem Biophys Res Commun (1969) 1.12
A new mechanism of exogenous hyperglyceridemia. Ann Intern Med (1969) 1.11
Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis. J Lipid Res (1985) 1.11
Lipid abnormalities in foam cell reticulosis of mice, an analogue of human sphingomyelin lipidosis. J Lipid Res (1969) 1.10
Neuropathy in Tangier disease. Alpha-Lipoprotein deficiency manifesting as familial recurrent neuropathy and intestinal lipid storage. Arch Neurol (1967) 1.09
Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia. Proc Natl Acad Sci U S A (1983) 1.08
Genetic analysis of plasma sitosterol, apoprotein B, and lipoproteins in a large Amish pedigree with sitosterolemia. Am J Hum Genet (1986) 1.08
Hyperapobetalipoproteinaemia in two families with xanthomas and phytosterolaemia. Lancet (1981) 1.07
Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res (1993) 1.06
Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors. J Biol Chem (2000) 1.06
The field trial: some thoughts on the indispensable ordeal. Bull N Y Acad Med (1968) 1.06
Beta-sitosterolemia and xanthomatosis. N Engl J Med (1976) 1.05
Observations on the conformation of human beta lipoprotein: evidence for the occurrence of beta structure. Proc Natl Acad Sci U S A (1968) 1.05
Fractionation of the C-apoproteins from human plasma very low density lipoproteins. J Biol Chem (1973) 1.05
Amelioration of hypertriglyceridaemia by progestational drugs in familial type-V hyperlipoproteinaemia. Lancet (1969) 1.05
An international classification of hyperlipidemias and hyperlipoproteinemias. Ann Intern Med (1971) 1.04
The National Heart Institute Twin Study. Acta Genet Med Gemellol (Roma) (1971) 1.03
Properties of the plasma very low and low density lipoproteins in Tangier disease. J Clin Invest (1978) 1.03
Human serum beta-lipoprotein: preparation and properties of a delipidated, soluble derivative. Biochem Biophys Res Commun (1968) 1.03
High-affinity uptake and degradation of apolipoprotein E free high-density lipoprotein and low-density lipoprotein in cultured porcine hepatocytes. Biochemistry (1982) 1.03
Biomedical research in the 1980s. N Engl J Med (1981) 1.02
On thelipoprotein abnormality in type 3 hyperlipoproteinemia. J Clin Invest (1971) 1.02
An HphI polymorphism in the E-selectin gene is associated with premature coronary artery disease. Clin Genet (2001) 1.01
Norethindrone acetate, postheparin lipolytic activity, and plasma triglycerides in familial types I, 3, IV, and V hyperlipoproteinemia. Studies in 26 patients and 5 normal persons. Ann Intern Med (1971) 1.01
Gaucher's disease of the lung causing severe pulmonary hypertension with associated acute recurrent pericarditis. Circulation (1967) 1.01
Changes in high-density lipoprotein protein composition after heparin-induced lipolysis. Am J Physiol (1971) 1.01
Partial delipidation of human serum beta-lipoprotein by sodium decyl sulfate. Biochim Biophys Acta (1969) 0.99
Beta-galactosidase in tissue culture derived from human skin and bone marrow. Enzyme defect in GM1 gangliosidosis. Pediatr Res (1969) 0.99
Evidence for separate monoglyceride hydrolase and triglyceride lipase in post-heparin human plasma. J Lipid Res (1969) 0.98
The structure and properties of human beta-lipoprotein and beta-apoprotein. Biochem Biophys Res Commun (1968) 0.97
Hyperapobetalipoproteinemia in a kindred with familial combined hyperlipidemia and familial hypercholesterolemia. Arteriosclerosis (1987) 0.97
Acquired type I hyperlipoproteinemia with systemic lupus erythematosus, dysglobulinemia and heparin resistance. Am J Med (1969) 0.97
Cutaneous cholesterol ester deposition in Tangier disease. Arch Dermatol (1967) 0.97
miniSAGE: gene expression profiling using serial analysis of gene expression from 1 microg total RNA. Anal Biochem (2000) 0.97